Article Text

Download PDFPDF

Diffuse normolipaemic plane xanthoma in a patient with monoclonal gammopathy
  1. Sónia Raquel Mendes,
  2. Ana Rita Gameiro,
  3. Inês Coutinho and
  4. José Carlos Cardoso
  1. Dermatology Department, Coimbra University Hospital, Coimbra, Portugal
  1. Correspondence to Dr Sónia Raquel Mendes; soniaraquel23{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


A 70-year-old female Caucasian patient presented with a 7 year-history of extensive yellow papules and macules scattered over the trunk and upper limbs, with mild pruritus (figure 1).

Figure 1

Extensive yellow papules and macules scattered over the trunk and upper limb.

No other body areas were involved, and she did not have other relevant skin lesions.

The patient had no history of previous infectious diseases, of trauma in the last months or any recently started medicines.

Subsequent investigation led to the diagnosis of diffuse plane xanthoma associated with monoclonal gammopathy of undetermined significance.

The diagnosis of diffuse plane xanthoma was confirmed histologically by the presence of clusters of foamy histiocytes, with perivascular and interstitial distribution in the superficial and middle dermis (figure 2).

Figure 2

Xantomised histiocyte collections in the superficial and middle dermis (H&E, ×40), with little inflammatory infiltrate (H&E, ×200).

She carried out a laboratorial workup that revealed a monoclonal IgG lambda gammopathy and is currently being followed in haematology by monoclonal gammopathy of undetermined significance.

Further workup did not reveal any significant abnormalities, namely dyslipidaemia.

Laser treatment was offered but declined by the patient.

Diffuse normolipaemic plane xanthoma (DNPX), which was first described by Altman and Winkelmann, is a rare acquired dermatosis of the subtype of the non-Langerhans histiocytoses group.1–3 Clinically, it is characterised by the presence of symmetric flat yellow macular areas or slightly elevated yellow-orange plaques, gradually appear, with a predilection for the eyelids (xanthelasma palpebrarum), neck, upper trunk and flexural folds.1–4 DNPX occurs mainly in adults and is associated with normal plasma lipid levels.1 3 4 Histologically, foam cells (macrophages) and variable numbers of Touton giant cells, lymphocytes and foamy histiocytes are present; sometimes only foam cells can be seen.1 The pathogenesis is still unclear, however, in gammopathy-associated DNPX, monoclonal IgG is thought to bind to circulating low-density lipoprotein (LDL), rendering the antibody-LDL complex more susceptible to phagocytosis by macrophages.2 Over half of the reported cases of DNPX are associated with lymphoproliferative disorders.2 DNPX has been recognised to be associated with haematological diseases, especially with multiple myeloma, monoclonal gammopathy or monoclonal gammopathy of undetermined significance, chronic granulocytic or lymphatic leukaemia, Waldenström’s macroglobulinaemia, cryoglobulinaemia and lymphoma.1–5 DNPX may precede the onset of these diseases over several years, and clinical and laboratory monitoring is recommended periodically, even for patients who appear to have no underlying condition.2 3 DNPX does not cause significant health problems although the lesions can be cosmetically disfiguring; there are currently several treatment options available.3 In patients with limited involvement, individual lesions can be excised.3 Other options include chemabrasion, dermabrasion and ablative laser therapy, such as erbium-doped yttrium aluminium garnet (Er:YAG) laser treatment.3

Learning points

  • Diffuse normolipaemic plane xanthoma is a rare dermatosis that occurs mainly in adults, and may associated with monoclonal gammopathy.

  • This case demonstrates the importance of cutaneous manifestations as a clue of important haematological diseases, which should motivate clinicians to be familiar with this entity.

Ethics statements



  • Contributors SRM (first author): acquisition and analysis of data, planning, conducting, conception and design of the article, as well as revision and final approval. ARG: acquisition of data and final approval. IC: acquisition of data and final approval. JCC: acquisition of data, revision and final approval.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.